Eurobiol
mixture of lyopholized pancreas, ascorbic acid, lactose, dry extract of sweet orange juice, sachet, silica gel and starch; used in treatment of cystic fibrosis
Networked: 6
relevant articles (1 outcomes,
1 trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Related Diseases
1. | Cystic Fibrosis (Mucoviscidosis)
|
2. | Exocrine Pancreatic Insufficiency
01/01/1989
- " The efficacy and tolerability of P were compared to those of Eurobiol (E) (PE lacking enteric coating) in patients with exocrine pancreatic insufficiency (PI) via an open crossover study conducted at 16 centers in France. " 01/01/1989
- " The purpose of this article is to validate an experimental model that produces total pancreatic insufficiency in pigs, and to study the fate of orally administered Eurobiol, a whole pancreas lyophilized preparation, and its effects on circulating plasma levels of five digestive hormones. " 08/01/1991
- " The effect on steatorrhoea of a pH-sensitive enteric-coated pancreatic preparation (Eurobiol 25,000) was compared with a conventional pancreatic enzyme preparation (Eurobiol) in six adult patients with exocrine pancreatic insufficiency. " 10/01/1988
- " [Comparative study of Creon and Eurobiol in the treatment of exocrine pancreatic insufficiency in adults]." 01/01/1989
- " In pigs with pancreatic insufficiency, Eurobiol, given during the meal, induced a significant increase in all enzyme activities in the duodenum and the jejunum, and in the levels of amylase, trypsin, and chymotrypsin in the ileum, relative to placebo. "
|
3. | Steatorrhea
|
|
Related Drugs and Biologics
Related Therapies and Procedures